Member Info for Pingu777

Pre-clinical pharma not for you cyrox. Simples. You have unrealistic timescales and expectations.

Good luck Mornington. I completely disagree of course. HEMO downside risk from here compared to the blue sky into which they are slowly but very surely moving is incomparable by any other share.

Happy for folk to chase shorter term rises elsewhere and increase their risk. Whatever floats your boat. But HEMOs rise is inevitable. Best place for anyone’s cash imo.

And it’s all a game of opinions!

Love how there are people disappointed after another great RNS. Short sighted short term rainbow chasers who want over night miracles.

HEMO continue to do amazing things and I am happy to see the back of short sighted nay sayers. We are building nicely and people never happy with hemo should stay away!

HEMO is and will deliver transformational shareholder growth.

Sammm
- Covid update any time on novel test and antibody treatment/cure
- CDX contract deal with Eli
- HEMO CAR T IND-enabling testing results
-HEMO CAR T partnership with big pharma
- HuPech pre-clinical testing Update (not far off ready for FDA app)
- mice development update with Eli
- mice revenue update
- Lupus development update both independently and work with J&J and Eli
- ORGS POC linked in with HEMO CAR T and HUPECH
- ORGS Mice distribution
- ORGS BIODEFENSE PLATFORM testing and take up
-

Higgs knows the blockchain game and have bought big in CTEA. They’ve obviously seen something they like.

New director reward scheme only begins paying when 10p is held for over two weeks and then increments up to 50p! Would be meaningless for the Directors unless these targets were achievable.

The product works and is vital to our return to something near normality. News next week for me.

We all know that the SP here flies quickly. I’ve said before I think the quiet bodes well as they’re not stringing PIs along with flimsy updates. They wanna hit the market with something material. A big positive for me.

Big lad you’re v negative mate. Surely you can only judge a company as little as CTEA based on their RNSs and developments or failures shared. Just because it’s quiet and based on literally no RNS you have written them off?

Do you think COVID is going away? We’ve just had a local council update saying we can’t have any spectators at my weekend cricket match. Madness. But very real.

What’s 5 weeks in a pandemic that is not ending any time soon?

Fair point lunus. The echo of nothingness and emptiness extends far and wide from the pumpky. Good luck the guessers.

Agree Claire. The market is there and the product is good enough it seems. Just needs take up. Consortium will have access to plenty of clients and once it’s proven to be work and be useful then it could snowball.

Sorry Pumpky I was gonna moan about you but I couldn’t bring myself to. I find you really annoying but you’re not offensive or anything. Just seems to be everything you say about eating for the SP to dip and investing in tripe til you see fit. But there we are. Hope you’re making money.

I think my pain stems from HEMO being too good for you and that I don’t think you deserve to be invested. But there we are.

This post could get removed :-()

Anyway, good luck still.

Mike, providing you give HEMO enough time it will provide astronomical returns in the coming months and years. Trust in HEMOs vision, skills and leadership. Marx Feldmann says they will create significant share holder value over the next 12 months from April and the company is reaching an inflection point In its development during this period. Read his CV on the hemo site. He knows the drill and has seen it all before.

It’s a short time since it was available for commercial roll out, too short a time to have a got ‘new’ clients through the door and signed up. But you would hope that they’ve had a shortlist of potential customers interested since the idea was announced and who were interested in taking things forward once the trial proved it works.

The consortium has a fair range of customer types and sizes between them.

Jarv that link didn't work or me.

Jo80, so what do you see CTEA actually having for us in their next update? What do you think they should be offering? Do you think it could be a money making/in demand app?

jo80 keeping it real.
Got anything remotely positive to contribute?

From what I have read and researched (RNSs etc) I expect that GlobalCo (Eli ) will sign the deal and take CDX forward to human trials. Yet, the SP does not reflect this fact. The biggest confirmation for me was the "culturally aligned" quote in Vlad's last video and that we work really well together when collaborating. Amongst may other indicators this is alignment of patient focus drives both Vlad and Eli. Both take the same approach that profits will follow if we advance treatments and save lives.

You only need to look at all the other Big Pharma and Eli Lilly is the only one who does not include commercially focussed references in their corporate messages and strap lines etc.

So again, the current market quite clearly does not see the same levels of inevitability of this deal as me and therefore prices HEMO as such. This is where I get my edge as I believe the probability of the deal completing is higher than reflected in the SP. Therefore making this a bargain at current prices.

And CDX is a SINGLE PRODUCT for Hemo. It boggles my mind that we're still so cheap on the cusp of stardom. Complete validation (having got a small portion of validity already) will follow in the coming weeks and months.

The IND enabling test we're doing on HEMO CAR T, to which we have allocated £1.6M ( our previous annual cash burn) tells me we will be flying through this testing phase and be in negotiations now with partners we speak. News of this progress will be sooner than people think and will lead to a multi million pound deal with upfront and milestone payments. Furthermore, we will have funded fully the entire pre-clinical testing so whatever we get for the CDX deal... it'll likely be even more for HEMO CAR T.

With the CDX deal we could be provided with some phase 1 testing results by the end of the year if they get cracking soon. Just imagine CDX saving relapsed AML patients lives? Nice headline hey, without a splash of chemo is sight. Suddenly, the drug is validated, the mice are validated, our other drugs that work on the mice are validated...

I will have amassed an excellent collection of rocket GIFs and pics by then to do the SP justice.

Look after those HEMO shares people :-)

I agree with the view it will be very hard to secure financial deals in such a short timescale. So people need to be realistic about what they expect. In MoU type talks with a few big employers would be my ideal.

Again, with Botswana what can you expect in just over a month? People need to keep their expectations in check! Decent initial interest in private companies and maybe local government enterprises? No idea how it’ll progress to be fair.

Could announce a COVID antibody testing partner?

what I do see is that the world needs these “return to work” style apps that can accurately record testing results as more and more testing will happen across the world. Private companies will need to demonstrate that they’re taking safety precautions with employees and all staff. A return to semi-normality is a long road and and a testing record with blockchain is a solid tool to assist.

I just hope the consortium enables CTEA to get the ear of the appropriate audience.

So how are people reading the radio silence? Struggling for customers or sorting some serious deals? For me, the longer it goes with no news the less desperate CTEA would seem to be to pacify investors which tells me they might have something good for us. Think about it, if they were struggling they'd be firing out flimsy progress updates. Hopefully the next news is worth waiting for.

i bought twice at 7.6p

Joey my view is not based on any other share. My view is based on what milestones I expect to be reached by the middle of next year. With added confidence and support taken from Sir Marc Feldmanns YEAR END commentary.

Just your gut? Hmmm. So the deadline extension runs to Sept 1. But then they won’t have made their mind up at that point or just general delays in paper work or organising trials or what?

Interested to know.